Canlyniadau Chwilio - Angeline Zhu
- Dangos 1 - 2 canlyniadau o 2
-
1
Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up gan Martin Dreyling, André Goy, Georg Heß, Brad S. Kahl, José‐Ángel Hernández‐Rivas, Natasha Schuier, Keqin Qi, Sanjay Deshpande, Angeline Zhu, Lori Parisi, Michael Wang
Cyhoeddwyd 2022Artigo -
2
Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts gan Peter Martin, Jonathon B. Cohen, Michael Wang, Anita Kumar, Brian T. Hill, Diego Villa, Jeffrey M. Switchenko, Brad S. Kahl, Kami J. Maddocks, Natalie S. Grover, Keqin Qi, Lori Parisi, K. Daly, Angeline Zhu, Gilles Salles
Cyhoeddwyd 2022Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Chemoimmunotherapy
Chemotherapy
Internal medicine
Lymphoma
Mantle cell lymphoma
Medicine
Oncology
Rituximab
Astrobiology
Autologous stem-cell transplantation
Bendamustine
Chronic lymphocytic leukemia
Clinical trial
Cohort
Confidence interval
Cytarabine
Hazard ratio
Ibrutinib
Leukemia
Physics
Progression-free survival
Refractory (planetary science)
Retrospective cohort study
Surgery
Transplantation